Stay updated with breaking news from Fellow Shareholders. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
LONDON, Jan. 25, 2022 /PRNewswire/ -- Apollon Formularies plc (AQSE: APOL) , ("Apollon" or the "Company"), a UK based international pharmaceutical company specializing in medical cannabis and
Press release content from Accesswire. The AP news staff was not involved in its creation.
/PRNewswire/ -- Apollon Formularies plc (AQSE: APOL) , ("Apollon" or the "Company"), a UK based international pharmaceutical company specializing in medical...
LONDON, UK / ACCESSWIRE / January 25, 2022 / Apollon Formularies plc (AQSE:APOL)('Apollon' or the 'Company'), a UK based international pharmaceuti...
LONDON, UK / ACCESSWIRE / January 25, 2022 / Apollon Formularies plc (AQSE:APOL)("Apollon" or the "Company"), a UK based international pharmaceutical company specializing in medical cannabis and trading